🔎 Trials Near Me

Beranda › Kanker Prostat › Maryland › Baltimore

Uji klinis Kanker Prostat di Baltimore, MD

43 studi untuk Kanker Prostat mencari peserta di lokasi sekitar Baltimore (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Menerima pesertaFase 3
  • Maryland Proton Treatment Center, Baltimore
  • University of Maryland/Greenebaum Cancer Center, Baltimore
  • UM Baltimore Washington Medical Center/Tate Cancer Center, Glen Burnie · 9 mi jauhnya
  • dan 1 lainnya
Usia 18 ke atas · Pria · Diperbarui 2 Okt 2026 · NCT07200830

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Mercy Medical Center, Baltimore
  • Sinai Hospital of Baltimore, Baltimore
  • MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
  • dan 2 lainnya
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Menerima pesertaFase 2
  • Johns Hopkins University, Baltimore
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06172478

Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix

Menerima pesertaStudi observasional
  • Chesapeake Urology Associates, Towson · 8 mi jauhnya
Usia 40 hingga 75 · Pria · Diperbarui 28 Sep 2026 · NCT07543757

Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

Menerima pesertaFase 1
  • University of Maryland, Greenebaum Comprehensive Cancer Center, Baltimore
Usia 18 ke atas · Pria · Diperbarui 25 Sep 2026 · NCT06801236

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

Menerima pesertaFase 3
  • Baltimore Veterans Affairs Medical Center ( Site 0069), Baltimore
  • Greenebaum Comprehensive Cancer Center ( Site 0049), Baltimore
  • Chesapeake Urology ( Site 0009), Towson · 8 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06136650

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

Menerima pesertaFase 3
  • University of Maryland Greenebaum Cancer Center, Baltimore
  • Johns Hopkins Hospital Sidney Kimmell Comprehensive Cancer Center, Baltimore
Usia 18 ke atas · Pria · Diperbarui 22 Sep 2026 · NCT07213674

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

Menerima pesertaFase 3
  • Research Site, Towson · 8 mi jauhnya
Usia 18 ke atas · Pria · Diperbarui 18 Sep 2026 · NCT06952803

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

Menerima pesertaFase 3
  • Greenebaum Comprehensive Cancer Center ( Site 0021), Baltimore
Usia 18 ke atas · Pria · Diperbarui 17 Sep 2026 · NCT06925737

PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness

Menerima pesertaStudi observasional
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Usia 18 ke atas · Pria · Diperbarui 15 Sep 2026 · NCT04995198

A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec

Menerima pesertaFase 2
  • Chesapeake Urology Research Associates, Towson · 8 mi jauhnya
Usia 18 ke atas · Pria · Diperbarui 15 Sep 2026 · NCT07332000

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

Menerima peserta
  • Anne Arundel Urology, Annapolis · 22 mi jauhnya
Usia 18 ke atas · Pria · Diperbarui 14 Sep 2026 · NCT06511141

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Menerima pesertaFase 3
  • Maryland Proton Treatment Center, Baltimore
  • University of Maryland/Greenebaum Cancer Center, Baltimore
  • Veterans Administration Medical Center-Baltimore, Baltimore
  • dan 4 lainnya
Usia 18 ke atas · Pria · Diperbarui 10 Sep 2026 · NCT05946213

Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients

Menerima peserta
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06138067

Transrectal Ultrasound Robot-Assisted Prostate Biopsy

Menerima peserta
  • Johns Hopkins Hospital, Baltimore
Usia 45 hingga 75 · Pria · Diperbarui 26 Agu 2026 · NCT02871726

Study of Oral MRT-2359 With Apalutamide in Prostate Cancer

Menerima pesertaFase 2
  • University of Maryland Greenebaum Cancer Center, Baltimore
Usia 18 ke atas · Pria · Diperbarui 24 Agu 2026 · NCT07745361

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

Menerima pesertaFase 1/2
  • Johns Hopkins Hospital, Baltimore
Usia 18 ke atas · Pria · Diperbarui 20 Agu 2026 · NCT06785636

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Menerima pesertaFase 3
  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Usia 18 ke atas · Pria · Diperbarui 19 Agu 2026 · NCT04423211

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Menerima pesertaFase 1/2
  • Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center, Baltimore
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT05919264

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

Menerima pesertaFase 1
  • University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
Usia 18 hingga 100 · Pria · Diperbarui 13 Agu 2026 · NCT05519449

Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer

Menerima pesertaStudi observasional
  • Johns Hopkins University, Baltimore
Usia 18 ke atas · Pria · Diperbarui 12 Agu 2026 · NCT04489719

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Menerima pesertaFase 3
  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Usia 18 ke atas · Pria · Diperbarui 14 Jul 2026 · NCT06592924

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

Menerima pesertaFase 2
  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Usia 18 ke atas · Pria · Diperbarui 14 Jul 2026 · NCT05691465

Study of ORIC-944 in Patients With Metastatic Prostate Cancer

Menerima pesertaFase 1
  • Marlene & Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore
Usia 18 ke atas · Pria · Diperbarui 9 Jul 2026 · NCT05413421

7-Days Water-Only Fasting or Ketone Supplementation Trial in Prostate Cancer

Menerima peserta
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Usia 18 ke atas · Pria · Diperbarui 30 Jun 2026 · NCT06826924

The COSMYC Trial (COmbined Suppression of MYC)

Menerima pesertaFase 2
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Usia 18 ke atas · Pria · Diperbarui 18 Jun 2026 · NCT06922318

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

Menerima pesertaFase 1
  • Advanced Molecular Imaging and Therapy, Glen Burnie · 9 mi jauhnya
  • United Theranostics - Chesapeake, Glen Burnie · 9 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Jun 2026 · NCT05283330

TERPS Trial for de Novo Oligometastic Prostate Cancer

Menerima pesertaFase 2
  • Maryland Proton Treatment Center, Baltimore
  • UMMC, Baltimore
  • Baltimore Washington Medical Center, Glen Burnie · 9 mi jauhnya
  • dan 1 lainnya
Usia 18 ke atas · Pria · Diperbarui 3 Jun 2026 · NCT05223803

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

Menerima pesertaStudi observasional
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Usia 21 ke atas · Pria · Diperbarui 22 Mei 2026 · NCT03151629

Clinical Trial of Approaches to Prostate Cancer Surgery

Menerima peserta
  • Johns Hopkins University, Baltimore
Usia 40 hingga 80 · Pria · Diperbarui 22 Apr 2026 · NCT05155501

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

Menerima pesertaFase 2/3
  • Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, Baltimore
Usia 18 ke atas · Pria · Diperbarui 8 Apr 2026 · NCT04787744

SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization

Menerima pesertaStudi observasional
  • Johns Hopkins University, Baltimore
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 30 Mar 2026 · NCT06389097

Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response

Menerima pesertaFase 2
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Usia 18 ke atas · Pria · Diperbarui 11 Mar 2026 · NCT07142551

Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer

Menerima pesertaFase 2
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Usia 18 ke atas · Pria · Diperbarui 19 Feb 2026 · NCT06616597

Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT

Menerima pesertaFase awal 1
  • SKCCC at Johns Hopkins, Baltimore
Usia 18 hingga 100 · Pria · Diperbarui 13 Feb 2026 · NCT03861676

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Menerima pesertaFase 1
  • Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center, Baltimore
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Feb 2026 · NCT06778863

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

Menerima pesertaFase 1
  • Chesapeake Urology, Towson · 8 mi jauhnya
Usia 18 ke atas · Pria · Diperbarui 4 Feb 2026 · NCT04729114

Physician- and Patient-based Barriers to NGS Testing

Menerima peserta
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Usia 18 ke atas · Pria · Diperbarui 3 Feb 2026 · NCT07209176

Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer

Menerima pesertaFase 2
  • Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center, Baltimore
Usia 18 ke atas · Pria · Diperbarui 14 Jan 2026 · NCT06059118

Robot-Assisted Prostate Biopsy With a Novel Ultrasound Probe

Menerima pesertaFase 1
  • Johns Hopkins Hospital, Baltimore
Usia 40 hingga 75 · Pria · Diperbarui 8 Des 2025 · NCT07271017

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Menerima pesertaStudi observasional
  • Massive Bio SYNERGY-AI site, Baltimore
  • Massive Bio SYNERGY-AI site, Towson · 8 mi jauhnya
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

Exercise in Prostate Cancer

Menerima peserta
  • Johns Hopkins University, Baltimore
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 20 Okt 2025 · NCT06165302

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

Menerima pesertaFase 1/2
  • Johns Hopkins, Baltimore
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Mei 2025 · NCT04503265

Uji klinis Kanker Prostat di kota lain

Studi lain di Baltimore

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.